ID: ALA3645250

Max Phase: Preclinical

Molecular Formula: C30H35F4N5O3

Molecular Weight: 589.63

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(C)(C)[C@H](c1nc(-c2cc(F)ccc2F)nn1Cc1cccc(F)c1)N(C[C@@H]1CNC[C@@H]1F)C(=O)[C@@H]1CCCO1

Standard InChI:  InChI=1S/C30H35F4N5O3/c1-30(2,41-3)26(38(17-19-14-35-15-24(19)34)29(40)25-8-5-11-42-25)28-36-27(22-13-21(32)9-10-23(22)33)37-39(28)16-18-6-4-7-20(31)12-18/h4,6-7,9-10,12-13,19,24-26,35H,5,8,11,14-17H2,1-3H3/t19-,24-,25-,26-/m0/s1

Standard InChI Key:  HSPPNWKZHJPJBS-UBLBMGLWSA-N

Associated Targets(Human)

Kinesin-like protein 1 1720 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 589.63Molecular Weight (Monoisotopic): 589.2676AlogP: 4.44#Rotatable Bonds: 10
Polar Surface Area: 81.51Molecular Species: BASEHBA: 7HBD: 1
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.47CX LogP: 4.23CX LogD: 2.18
Aromatic Rings: 3Heavy Atoms: 42QED Weighted: 0.35Np Likeness Score: -0.97

References

1.  (2013)  Triazole compounds as KSP inhibitors, 

Source

Source(1):